TC Biopharm (Holdings) Plc
TCBPY
$0.3088
-$0.0062-1.97%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -110.63% | -229.85% | -769.76% | -316.97% | -398.51% |
| Total Depreciation and Amortization | -29.18% | -19.19% | -8.00% | -14.29% | -18.30% |
| Total Amortization of Deferred Charges | -- | -70.49% | -55.95% | -55.95% | -55.95% |
| Total Other Non-Cash Items | 117.83% | 118.85% | 119.78% | 53.06% | 19.14% |
| Change in Net Operating Assets | -234.86% | 51.14% | 115.84% | 124.28% | 123.54% |
| Cash from Operations | -22.82% | 6.40% | 30.34% | 24.20% | 31.35% |
| Capital Expenditure | 38.95% | 92.00% | 107.38% | 102.92% | 53.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 69.83% | 58.40% | 47.42% | 27.58% | 21.30% |
| Cash from Investing | 53.73% | 80.52% | 93.48% | 82.56% | 31.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 184.32% | 203.17% | 244.79% | 12.00% | 24.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -110.14% | -91.14% | -80.75% | -87.59% | -75.79% |
| Cash from Financing | 39.61% | 12.54% | -11.99% | -64.62% | -55.32% |
| Foreign Exchange rate Adjustments | 52.45% | -4.87% | -154.43% | -249.52% | -155.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 46.89% | 65.69% | 76.89% | -339.85% | -168.11% |